ARS Pharmaceuticals, Inc (SPRY) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.11 (-0.96%), Market cap $0.80B, 52-week low–high $6.73 ~ $18.35.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for ARS Pharmaceuticals, Inc are updated in real time on BlackAll Trade.
ARS Pharmaceuticals, Inc trades at $4.11 (-0.96%). Real-time quotes and charts are available on BlackAll Trade.
ARS Pharmaceuticals, Inc has a market cap of about $0.80B.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the de